Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

February 01, 1989; Volume 248,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aamodt, R

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  2. Abrahams, T P

    1. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;
  3. Adejare, A

    1. You have access
      Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;
  4. Aharony, D

    1. You have access
      Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
      D Aharony, C A Catanese and R C Falcone
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 581-588;
  5. Alberts, A W

    1. You have access
      Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;
  6. Anders, M W

    1. You have access
      Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells.
      L H Lash and M W Anders
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 531-537;
  7. Araki, S

    1. You have access
      Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;
  8. Atchison, J A

    1. You have access
      Colonic absorption of insulin: an in vitro and in vivo evaluation.
      J A Atchison, W E Grizzle and D J Pillion
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 567-572;
  9. Atchison, W D

    1. You have access
      Block of 45Ca uptake into synaptosomes by methylmercury: Ca++- and Na+-dependence.
      T J Shafer and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 696-702;

B

  1. Bannon, M J

    1. You have access
      Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
      D M Haverstick, A Rubenstein and M J Bannon
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 858-862;
  2. Barry, W H

    1. You have access
      Mechanism of protective effects of Ca++ channel blockers on energy deprivation contracture in cultured ventricular myocytes.
      O Kohmoto and W H Barry
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 871-878;
  3. Barzaghi, G

    1. You have access
      Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
      G Barzaghi, H M Sarau and S Mong
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 559-566;
  4. Bedotto, J B

    1. You have access
      Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;
  5. Bend, J R

    1. You have access
      Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;
  6. Botella, J

    1. You have access
      Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;
  7. Bowyer, J F

    1. You have access
      K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
      J F Bowyer and N Weiner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 514-520;
  8. Brown, B S

    1. You have access
      Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
      B S Brown
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 552-558;
  9. Burch, R M

    1. You have access
      [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;

C

  1. Catanese, C A

    1. You have access
      Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
      D Aharony, C A Catanese and R C Falcone
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 581-588;
  2. Chow, D D

    1. You have access
      Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;
  3. Civiale, M A

    1. You have access
      Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;
  4. Clow, D W

    1. You have access
      Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.
      D W Clow and K Jhamandas
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 722-728;
  5. Compton, D R

    1. You have access
      Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
      D R Compton and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 521-530;
  6. Coulson, R

    1. You have access
      Xanthine effects on renal proximal tubular function and cyclic AMP metabolism.
      R Coulson and S J Scheinman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 589-595;
  7. Coyle, J T

    1. You have access
      Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;
  8. Cubeddu, L X

    1. You have access
      Effects of low extracellular chloride on dopamine release and the dopamine transporter.
      P A Diliberto, R A Jeffs and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 644-653;

D

  1. Dandapani, B K

    1. You have access
      Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;
  2. Dehaas, C J

    1. You have access
      [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;
  3. Delansorne, R

    1. You have access
      Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;
  4. Diliberto, P A

    1. You have access
      Effects of low extracellular chloride on dopamine release and the dopamine transporter.
      P A Diliberto, R A Jeffs and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 644-653;
  5. Docherty, J R

    1. You have access
      Canine pulmonary artery contains a homogeneous population of alpha-1 adrenoceptors.
      J R Docherty and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 479-483;
    2. You have access
      An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
      J R Docherty
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 736-740;
  6. Duc, I

    1. You have access
      Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;
  7. Duchai, D M

    1. You have access
      Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;

E

  1. Easington, C

    1. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;
  2. Efange, S

    1. You have access
      Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;
  3. Eilam, Y

    1. You have access
      Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;
  4. Epstein, S E

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  5. Eschalier, A

    1. You have access
      Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;
  6. Essien, H E

    1. You have access
      Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;

F

  1. Falcone, R C

    1. You have access
      Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
      D Aharony, C A Catanese and R C Falcone
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 581-588;
  2. Farmer, S G

    1. You have access
      [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;
  3. Fertel, R

    1. You have access
      Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;
  4. Feuerstein, G

    1. You have access
      Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;
  5. Fialip, J

    1. You have access
      Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;
  6. Fixler, R

    1. You have access
      Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;
  7. Foureman, G L

    1. You have access
      Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;
  8. Fraser, C M

    1. You have access
      Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;
  9. Fujiwara, M

    1. You have access
      Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;
  10. Furchgott, R F

    1. You have access
      Interactions of light and sodium nitrite in producing relaxation of rabbit aorta.
      K Matsunaga and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 687-695;

G

  1. Gallager, D W

    1. You have access
      Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of gamma-aminobutyric acid sensitivity.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 879-885;
    2. You have access
      Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. II. Modulation of firing rate.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 886-891;
  2. Garg, L C

    1. You have access
      Cholinergic stimulation of phosphoinositide hydrolysis in renal medullary collecting duct cells.
      S McArdle and L C Garg
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 682-686;
  3. Gay, R G

    1. You have access
      Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;
  4. Germershausen, J I

    1. You have access
      Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;
  5. Gessner, G

    1. You have access
      Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 637-643;
  6. Gillis, R A

    1. You have access
      Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
    2. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;
  7. Gnegy, M E

    1. You have access
      Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
      T Ryan-Jastrow and M E Gnegy
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 626-631;
  8. Goldman, S

    1. You have access
      Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;
  9. Goldstein, D S

    1. You have access
      Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;
  10. Goldstein, S R

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  11. Goto, K

    1. You have access
      Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;
  12. Graham, S D

    1. You have access
      Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;
  13. Greene, R

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  14. Grizzle, W E

    1. You have access
      Colonic absorption of insulin: an in vitro and in vivo evaluation.
      J A Atchison, W E Grizzle and D J Pillion
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 567-572;
  15. Grover, G J

    1. You have access
      Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
      G J Grover and W A Schumacher
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 484-491;
  16. Guengerich, F P

    1. You have access
      Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;
  17. Guidotti, A

    1. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

H

  1. Hadjiconstantinou, M

    1. You have access
      Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;
  2. Hallaq, H

    1. You have access
      Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;
  3. Hamada, A

    1. You have access
      Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;
  4. Hamosh, P

    1. You have access
      Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
    2. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;
  5. Harrington, B

    1. You have access
      Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
      T V Nowak, B Harrington and J H Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 573-580;
  6. Harris, C

    1. You have access
      Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
      G L Foureman, C Harris, F P Guengerich and J R Bend
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;
  7. Hasin, Y

    1. You have access
      Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
      H Hallaq, Y Hasin, R Fixler and Y Eilam
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;
  8. Haverstick, D M

    1. You have access
      Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
      D M Haverstick, A Rubenstein and M J Bannon
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 858-862;
  9. Hayashi, Y

    1. You have access
      Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;
  10. Hefti, F

    1. You have access
      Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;
  11. Henry, P J

    1. You have access
      Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
      P J Henry, J D Horowitz and W J Louis
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 762-768;
  12. Hill, K J

    1. You have access
      Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
  13. Hisa, H

    1. You have access
      Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;
  14. Horner, E

    1. You have access
      Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 637-643;
  15. Horowitz, J D

    1. You have access
      Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
      P J Henry, J D Horowitz and W J Louis
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 762-768;
  16. Hwang, K J

    1. You have access
      Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;

I

  1. Inada, I

    1. You have access
      Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  2. Inatomi, N

    1. You have access
      Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  3. Ishikawa, T

    1. You have access
      Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;
  4. Iwata, H

    1. You have access
      Veratrine-induced decrease of (Na+ + K+)-adenosine triphosphatase activity in rat brain slices.
      T Matsuda and H Iwata
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 729-735;

J

  1. Jeffs, R A

    1. You have access
      Effects of low extracellular chloride on dopamine release and the dopamine transporter.
      P A Diliberto, R A Jeffs and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 644-653;
  2. Jhamandas, K

    1. You have access
      Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.
      D W Clow and K Jhamandas
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 722-728;
  3. Johnson, K M

    1. You have access
      Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
      D R Compton and K M Johnson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 521-530;

K

  1. Kalbfleisch, J H

    1. You have access
      Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
      T V Nowak, B Harrington and J H Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 573-580;
  2. Kellar, K J

    1. You have access
      Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
  3. Kimes, A S

    1. You have access
      Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
      A S Kimes and E D London
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 538-545;
  4. Kirby, J S

    1. You have access
      Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
  5. Kohmoto, O

    1. You have access
      Mechanism of protective effects of Ca++ channel blockers on energy deprivation contracture in cultured ventricular myocytes.
      O Kohmoto and W H Barry
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 871-878;
  6. Kornbrust, D J

    1. You have access
      Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;
  7. Kubo, K

    1. You have access
      Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
  8. Kurahashi, K

    1. You have access
      Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;

L

  1. Lahlou, B

    1. You have access
      Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;
  2. Lai, J

    1. You have access
      Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;
  3. Langer, S Z

    1. You have access
      Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
      H Schoemaker and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 710-715;
  4. Laplante, C

    1. You have access
      Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
      C Laplante, B Tremblay and F Marceau
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 774-780;
  5. Lash, L H

    1. You have access
      Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells.
      L H Lash and M W Anders
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 531-537;
  6. Lichtensteiger, W

    1. You have access
      Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring.
      U Ribary and W Lichtensteiger
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 786-792;
  7. London, E D

    1. You have access
      Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
      A S Kimes and E D London
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 538-545;
  8. Louis, W J

    1. You have access
      Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
      P J Henry, J D Horowitz and W J Louis
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 762-768;

M

  1. MacDonald, J S

    1. You have access
      Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;
  2. Makambila, M C

    1. You have access
      Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;
  3. Maki, Y

    1. You have access
      Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
    2. You have access
      Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  4. Malik, K U

    1. You have access
      Uptake and hormonally induced hydrolysis of [3H]phosphatidyl choline in the isolated rabbit heart.
      M T Weis and K U Malik
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 614-620;
  5. Manabe, K

    1. You have access
      Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;
  6. Marceau, F

    1. You have access
      Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
      C Laplante, B Tremblay and F Marceau
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 774-780;
  7. Markle, D R

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  8. Marty, H

    1. You have access
      Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
      J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;
  9. Matsuda, T

    1. You have access
      Veratrine-induced decrease of (Na+ + K+)-adenosine triphosphatase activity in rat brain slices.
      T Matsuda and H Iwata
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 729-735;
  10. Matsunaga, K

    1. You have access
      Interactions of light and sodium nitrite in producing relaxation of rabbit aorta.
      K Matsunaga and R F Furchgott
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 687-695;
  11. McArdle, S

    1. You have access
      Cholinergic stimulation of phosphoinositide hydrolysis in renal medullary collecting duct cells.
      S McArdle and L C Garg
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 682-686;
  12. Mei, L

    1. You have access
      Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;
  13. Michel, P P

    1. You have access
      Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;
  14. Miller, D D

    1. You have access
      Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;
  15. Miyamoto, M

    1. You have access
      Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;
  16. Miyauchi, T

    1. You have access
      Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;
  17. Mong, S

    1. You have access
      Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
      G Barzaghi, H M Sarau and S Mong
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 559-566;
  18. Morin, D

    1. You have access
      Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
      S Urien, D Morin and J P Tillement
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 781-785;
  19. Morkin, E

    1. You have access
      Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
      J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;
  20. Morse, W H

    1. You have access
      Environmental determinants of enhanced sensitivity to the behavioral effects of naltrexone.
      P H Warren and W H Morse
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 546-551;
  21. Moummi, C

    1. You have access
      Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter.
      S Rattan and C Moummi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 703-709;

N

  1. Nagaoka, A

    1. You have access
      Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;
  2. Nagaya, H

    1. You have access
      Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
    2. You have access
      Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  3. Nakamura, N

    1. You have access
      Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  4. Namath, I J

    1. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;
  5. Narahashi, T

    1. You have access
      Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.
      N Ogata, M Nishimura and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 605-613;
  6. Narumi, S

    1. You have access
      Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
      M Miyamoto, S Narumi, A Nagaoka and J T Coyle
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;
  7. Neff, N H

    1. You have access
      Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;
  8. Nichols, A J

    1. You have access
      Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;
  9. Niida, H

    1. You have access
      Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;
  10. Nishimura, M

    1. You have access
      Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.
      N Ogata, M Nishimura and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 605-613;
  11. Nishiwaki, H

    1. You have access
      Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
  12. Nohara, A

    1. You have access
      Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  13. Norman, W P

    1. You have access
      Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
  14. Nowak, T V

    1. You have access
      Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
      T V Nowak, B Harrington and J H Kalbfleisch
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 573-580;

O

  1. Ogata, N

    1. You have access
      Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.
      N Ogata, M Nishimura and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 605-613;
  2. Okabe, S

    1. You have access
      Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
    2. You have access
      Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;
  3. Okada, M

    1. You have access
      Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
    2. You have access
      Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;

P

  1. Paakkari, P

    1. You have access
      Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;
  2. Padki, M M

    1. You have access
      Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
      D D Chow, H E Essien, M M Padki and K J Hwang
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;
  3. Paris, J

    1. You have access
      Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
      J Botella, I Duc, R Delansorne, J Paris and B Lahlou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;
  4. Patil, P N

    1. You have access
      Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;
  5. Patterson, R E

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  6. Pendleton, R G

    1. You have access
      Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.
      R G Pendleton, G Gessner and E Horner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 637-643;
  7. Peter, C P

    1. You have access
      Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;
  8. Pillion, D J

    1. You have access
      Colonic absorption of insulin: an in vitro and in vivo evaluation.
      J A Atchison, W E Grizzle and D J Pillion
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 567-572;
  9. Plante, G E

    1. You have access
      Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;
  10. Pressman, B C

    1. You have access
      Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;
  11. Prévost, C

    1. You have access
      Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;
  12. Prost, J F

    1. You have access
      Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;

Q

  1. Qu, Z X

    1. You have access
      Pharmacological characterization of rat retinal dopamine receptors.
      Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;
  2. Quest, J A

    1. You have access
      Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
      R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
    2. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;

R

  1. Rattan, S

    1. You have access
      Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter.
      S Rattan and C Moummi
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 703-709;
  2. Ribary, U

    1. You have access
      Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring.
      U Ribary and W Lichtensteiger
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 786-792;
  3. Ro, Y M

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  4. Rochat, C

    1. You have access
      Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;
  5. Roeske, W R

    1. You have access
      Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;
  6. Rubenstein, A

    1. You have access
      Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
      D M Haverstick, A Rubenstein and M J Bannon
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 858-862;
  7. Ruffolo, R R

    1. You have access
      Canine pulmonary artery contains a homogeneous population of alpha-1 adrenoceptors.
      J R Docherty and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 479-483;
    2. You have access
      Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
      A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;
  8. Ryan-Jastrow, T

    1. You have access
      Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
      T Ryan-Jastrow and M E Gnegy
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 626-631;

S

  1. Saito, A

    1. You have access
      Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;
  2. Sanchez-Ramos, J

    1. You have access
      Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
      P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;
  3. Sarau, H M

    1. You have access
      Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
      G Barzaghi, H M Sarau and S Mong
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 559-566;
  4. Satoh, H

    1. You have access
      Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
      H Nagaya, H Satoh, K Kubo and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
    2. You have access
      Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
      H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  5. Satoh, S

    1. You have access
      Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;
  6. Scheinman, S J

    1. You have access
      Xanthine effects on renal proximal tubular function and cyclic AMP metabolism.
      R Coulson and S J Scheinman
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 589-595;
  7. Schoemaker, H

    1. You have access
      Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
      H Schoemaker and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 710-715;
  8. Schumacher, W A

    1. You have access
      Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
      G J Grover and W A Schumacher
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 484-491;
  9. Shafer, T J

    1. You have access
      Block of 45Ca uptake into synaptosomes by methylmercury: Ca++- and Na+-dependence.
      T J Shafer and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 696-702;
  10. Shirahase, H

    1. You have access
      Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;
  11. Sirén, A L

    1. You have access
      Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
      A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;
  12. Sirois, P

    1. You have access
      Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
      G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;
  13. Speir, E

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  14. Steadman, K

    1. You have access
      Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
      Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  15. Steranka, L R

    1. You have access
      [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;
  16. Stubbs, R J

    1. You have access
      Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
      D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;
  17. Sugishita, Y

    1. You have access
      Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
      T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;

T

  1. Takeuchi, K

    1. You have access
      Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
    2. You have access
      Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
      K Takeuchi, M Okada, H Niida and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;
  2. Tanaka, H

    1. You have access
      Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
      H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
  3. Taveira da Silva, A M

    1. You have access
      Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
      R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;
  4. Tillement, J P

    1. You have access
      Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
      S Urien, D Morin and J P Tillement
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 781-785;
  5. Togo, J

    1. You have access
      [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
      S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;
  6. Tomura, Y

    1. You have access
      Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
      H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;
  7. Tremblay, B

    1. You have access
      Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
      C Laplante, B Tremblay and F Marceau
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 774-780;

U

  1. Urien, S

    1. You have access
      Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
      S Urien, D Morin and J P Tillement
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 781-785;
  2. Usui, H

    1. You have access
      Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
      H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;

V

  1. Venter, J C

    1. You have access
      Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;

W

  1. Warren, P H

    1. You have access
      Environmental determinants of enhanced sensitivity to the behavioral effects of naltrexone.
      P H Warren and W H Morse
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 546-551;
  2. Weiner, N

    1. You have access
      K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
      J F Bowyer and N Weiner
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 514-520;
  3. Weis, M T

    1. You have access
      Uptake and hormonally induced hydrolysis of [3H]phosphatidyl choline in the isolated rabbit heart.
      M T Weis and K U Malik
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 614-620;
  4. Wilson, M A

    1. You have access
      Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of gamma-aminobutyric acid sensitivity.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 879-885;
    2. You have access
      Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. II. Modulation of firing rate.
      M A Wilson and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 886-891;

Y

  1. Yamamura, H I

    1. You have access
      Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
      L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 248, Issue 2
1 Feb 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics